Tango Therapeutics, Inc.

NASDAQ (USD): Tango Therapeutics, Inc. (TNGX)

Last Price

3.56

Today's Change

+0.21 (6.26%)

Day's Change

3.31 - 3.79

Trading Volume

2,796,839

Overview

Market Cap

382 Million

Shares Outstanding

107 Million

Avg Volume

1,573,171

Avg Price (50 Days)

7.09

Avg Price (200 Days)

8.66

PE Ratio

-3.10

EPS

-1.15

Earnings Announcement

17-Mar-2025

Previous Close

3.35

Open

3.37

Day's Range

3.31 - 3.795

Year Range

2.7 - 13.005

Trading Volume

2,796,839

Price Change Highlight

1 Day Change

6.27%

5 Day Change

22.76%

1 Month Change

-48.10%

3 Month Change

-60.66%

6 Month Change

-51.30%

Ytd Change

-64.33%

1 Year Change

-52.97%

3 Year Change

-73.63%

5 Year Change

-65.20%

10 Year Change

-65.20%

Max Change

-65.20%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops Ubiquitin-specific protease 1, an inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. Tango Therapeutics, Inc. has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. The company was founded in 2017 and is based in Cambridge, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment